Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...